Tao Wang
About Tao Wang
Tao Wang is the Director and Team Lead of Biostatistics at Bristol Myers Squibb, with extensive experience in biostatistics roles at AstraZeneca, Eli Lilly, Johns Hopkins University, and The University of British Columbia.
Company
Tao Wang currently holds the position of Director and Team Lead - Biostatistics at Bristol Myers Squibb. His role involves overseeing statistical methodologies and data analysis within the company’s biostatistics department.
Title
As Director and Team Lead of Biostatistics, Tao Wang is responsible for leading a team of biostatisticians. His role includes coordinating statistical analysis efforts, ensuring data accuracy, and guiding the statistical component of clinical trials to support drug development and regulatory submissions.
Education and Expertise
Tao Wang earned his Doctor of Philosophy (PhD) in Statistics from The University of British Columbia. Prior to that, he completed his Bachelor of Science (BS) in Statistics at Nankai University. His academic training provided a foundation in statistical principles and methodologies, which he has applied throughout his career in the biostatistics field.
Professional Background
Tao Wang has a notable career spanning several prestigious organizations. He served as Associate Director - Biostatistics at AstraZeneca from 2016 to 2020 in Gaithersburg, Maryland. Prior to that, he worked at Eli Lilly and Company as a Senior Research Scientist and Research Scientist - Biostatistics from 2011 to 2016 in Indianapolis, Indiana. His earlier roles include being a biostatistician at The Johns Hopkins University and a Teaching/Research Assistant at The University of British Columbia.
Project Involvement
Throughout his career, Tao Wang has led and contributed to significant projects. At AstraZeneca, he led the global product statistics for Cotadutide and served as the interim therapeutic area head of cardiovascular, renal, and metabolism diseases at the Biologics unit. At Eli Lilly, he was the compound statistics lead for Humulin U-500 and served as a subject matter expert for insulin devices.